心肺体外循环设备市场:各市场区隔规模，占有率，法律规章，偿付，装置率(用户数)，2033年前的预测

体外循环机（CPB）是一种在心臟直视手术期间暂时接管心臟和肺部功能的设备。因此，它也被称为心肺机。该装置用于在血液返回动脉循环之前转移返回心臟的血液。心臟泵血，肺部提供红血球含氧血液。

CPB 通常用于各种心臟和非心臟手术。体外循环机用于心臟直视手术。该机器有助于绕过心臟，以便外科医生即使在手术期间心臟排空后也可以工作。一旦手术完成并且心臟开始正常工作，心肺机就会断开。心肺机在几个小时内接管心臟和肺的功能。

本报告提供全球心肺体外循环设备市场相关详细考察，提供市场上竞争情形，SWOT分析，到2033年前的市场预测，地区，各国的趋势等资讯。

目录

现在上市的心肺体外循环设备和竞争情形

• 主要的产业趋势的洞察
• 心肺体外循环设备的各市场区隔整体市场收益和2015年～2033年的市场展望
• 各市场区隔的手艺总数，台数，平均销售价格，市场价值相关详细资料

世界，地区，各国洞察

• 心肺体外循环设备市场SWOT分析
• 心肺体外循环设备市场相关竞争动态的洞察和趋势
• 各国医疗制度概要
• 各国偿付政策
• 各国医疗技术相关法规状况

Cardiopulmonary Bypass Equipment Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2033 is built to visualize quantitative and qualitative market trends within Cardiovascular Devices therapeutic area.

Cardiopulmonary bypass equipment temporarily takes over the function of heart and lungs during an open-heart surgery. Hence, also known as heart-lung machine. The equipment is used to divert the blood returning to the heart, before it returns to the arterial circulation. It works both as a heart i.e., pumps blood and as lungs i.e., supply oxygenated blood to the RBCs.

CPB is routinely used for various cardiac and non-cardiac surgical operations. Cardiopulmonary bypass machines are used during open-heart surgery. The machine helps to bypass the heart so that surgeons can work after the heart is emptied during the surgery. Once the surgery is done and heart starts pumping normally, the heart lung machine is disconnected. The heart-lung machine can take over the work of the heart and lungs for several hours.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with installed base. The interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Cardiopulmonary Bypass Equipment and evolving competitive landscape -

• Insightful review of the key industry trends.
• Annualized total Cardiopulmonary Bypass Equipment market revenue by segment and market outlooks from 2015-2033.
• Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Cardiopulmonary Bypass Equipment market.
• Competitive dynamics insights and trends provided for Cardiopulmonary Bypass Equipment market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: LivaNova Plc, Medtronic Plc, Terumo Corp, Getinge AB, Braile Biomedica Ltda, Senko Medical Instrument Manufacturing Co Ltd, Technowood Corp, Abiomed Inc, and Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the Cardiopulmonary Bypass Equipment marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products, by identifying key companies.
• Develop business strategies by understanding the trends shaping and driving Cardiopulmonary Bypass Equipment market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Cardiopulmonary Bypass Equipment market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific Cardiopulmonary Bypass Equipment market from 2015-2033.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.